These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31254552)

  • 1. Translational Prospects of ultrasound-mediated tumor immunotherapy: Preclinical advances and safety considerations.
    Xu W; Zhang X; Hu X; Zhiyi C; Huang P
    Cancer Lett; 2019 Sep; 460():86-95. PubMed ID: 31254552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances of ultrasound in tumor immunotherapy.
    Lin J; Wu Y; Liu G; Cui R; Xu Y
    Int Immunopharmacol; 2024 Jun; 134():112233. PubMed ID: 38735256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound in tumor immunotherapy: Current status and future developments.
    Ho YJ; Li JP; Fan CH; Liu HL; Yeh CK
    J Control Release; 2020 Jul; 323():12-23. PubMed ID: 32302759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.
    Oliver AJ; Lau PKH; Unsworth AS; Loi S; Darcy PK; Kershaw MH; Slaney CY
    Front Immunol; 2018; 9():70. PubMed ID: 29445373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutics for brain tumors: current practice and future prospects.
    El Demerdash N; Kedda J; Ram N; Brem H; Tyler B
    Expert Opin Drug Deliv; 2020 Jan; 17(1):9-21. PubMed ID: 31971041
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid-based microbubbles and ultrasound for therapeutic application.
    Omata D; Unga J; Suzuki R; Maruyama K
    Adv Drug Deliv Rev; 2020; 154-155():236-244. PubMed ID: 32659255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances of ultrasound-responsive nanosystems in tumor immunotherapy.
    Wang P; Chen J; Zhong R; Xia Y; Wu Z; Zhang C; Yao H
    Eur J Pharm Biopharm; 2024 May; 198():114246. PubMed ID: 38479562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy.
    Buabeid MA; Arafa EA; Murtaza G
    J Immunol Res; 2020; 2020():9624532. PubMed ID: 32377541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonodynamic therapy-derived multimodal synergistic cancer therapy.
    Xu M; Zhou L; Zheng L; Zhou Q; Liu K; Mao Y; Song S
    Cancer Lett; 2021 Jan; 497():229-242. PubMed ID: 33122099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy.
    Han Y; Sun J; Wei H; Hao J; Liu W; Wang X
    Front Immunol; 2022; 13():937344. PubMed ID: 35844515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological effect of local ablation combined with immunotherapy on solid malignancies.
    Takahashi Y; Matsutani N; Nakayama T; Dejima H; Uehara H; Kawamura M
    Chin J Cancer; 2017 Jun; 36(1):49. PubMed ID: 28592286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Opportunities and Challenges in Cancer Immunotherapy.
    Whiteside TL; Demaria S; Rodriguez-Ruiz ME; Zarour HM; Melero I
    Clin Cancer Res; 2016 Apr; 22(8):1845-55. PubMed ID: 27084738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference.
    Diken M; Chu KK; Brodsky AN
    Cancer Immunol Res; 2018 Jan; 6(1):10-13. PubMed ID: 29298782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment.
    Zhang N; Wang J; Foiret J; Dai Z; Ferrara KW
    Adv Drug Deliv Rev; 2021 Nov; 178():113906. PubMed ID: 34333075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
    Musetti S; Huang L
    ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
    Inthagard J; Edwards J; Roseweir AK
    Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on Recent Progress in Focused Ultrasound Immunotherapy.
    Sheybani ND; Price RJ
    Theranostics; 2019; 9(25):7749-7758. PubMed ID: 31695798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.